X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2900) 2900
Publication (208) 208
Book Review (24) 24
Book Chapter (10) 10
Magazine Article (10) 10
Newsletter (6) 6
Conference Proceeding (2) 2
Dissertation (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2282) 2282
acetazolamide - therapeutic use (1911) 1911
male (1236) 1236
female (1141) 1141
acetazolamide (1045) 1045
adult (777) 777
middle aged (696) 696
index medicus (659) 659
aged (466) 466
carbonic anhydrase inhibitors - therapeutic use (435) 435
ophthalmology (380) 380
animals (377) 377
clinical neurology (326) 326
diuretics - therapeutic use (296) 296
adolescent (279) 279
acetazolamide - pharmacology (271) 271
glaucoma - drug therapy (255) 255
intraocular pressure - drug effects (239) 239
child (221) 221
treatment outcome (221) 221
acetazolamide - administration & dosage (213) 213
pharmacology & pharmacy (211) 211
drug therapy, combination (185) 185
acetazolamide - adverse effects (175) 175
anticonvulsants - therapeutic use (160) 160
acute disease (149) 149
time factors (137) 137
altitude sickness - prevention & control (135) 135
rats (134) 134
neurosciences (131) 131
pseudotumor cerebri - drug therapy (127) 127
follow-up studies (125) 125
intraocular pressure (125) 125
carbonic anhydrase inhibitors - pharmacology (123) 123
surgery (121) 121
double-blind method (120) 120
visual acuity (120) 120
pediatrics (116) 116
aged, 80 and over (115) 115
medicine, general & internal (115) 115
retrospective studies (114) 114
prospective studies (112) 112
child, preschool (111) 111
altitude (109) 109
glaucoma (108) 108
magnetic resonance imaging (107) 107
administration, oral (105) 105
pilocarpine - therapeutic use (101) 101
carbonic anhydrase (99) 99
dexamethasone - therapeutic use (99) 99
hydrogen-ion concentration (99) 99
pseudotumor cerebri (99) 99
drug therapy (96) 96
infant (95) 95
risk factors (94) 94
care and treatment (93) 93
carbonic anhydrase inhibitors (91) 91
carbonic anhydrase inhibitors - administration & dosage (91) 91
idiopathic intracranial hypertension (91) 91
hypertension (89) 89
pseudotumor cerebri - diagnosis (88) 88
macular edema - drug therapy (86) 86
neurology (86) 86
timolol - therapeutic use (86) 86
medicine & public health (85) 85
intracranial hypertension (84) 84
hypoxia (83) 83
glaucoma - therapy (82) 82
diagnosis, differential (81) 81
dose-response relationship, drug (78) 78
mice (78) 78
research (78) 78
chronic disease (77) 77
sulfonamides - therapeutic use (77) 77
furosemide - therapeutic use (74) 74
diagnosis (73) 73
fluorescein angiography (72) 72
young adult (72) 72
administration, topical (70) 70
altitude sickness - drug therapy (69) 69
papilledema (68) 68
rabbits (68) 68
management (67) 67
pregnancy (66) 66
research article (66) 66
diuretics (65) 65
papilledema - etiology (65) 65
analysis (64) 64
antihypertensive agents - therapeutic use (64) 64
clinical trials as topic (64) 64
pseudotumor cerebri - complications (64) 64
pressure (63) 63
carbonic anhydrase inhibitors - adverse effects (62) 62
headache - etiology (62) 62
prevention (62) 62
chemistry, medicinal (61) 61
drugs (61) 61
cerebrovascular circulation - drug effects (60) 60
headache (60) 60
prognosis (60) 60
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2418) 2418
German (141) 141
French (91) 91
Spanish (54) 54
Japanese (48) 48
Italian (47) 47
Russian (41) 41
Romanian (19) 19
Czech (13) 13
Dutch (10) 10
Danish (9) 9
Polish (6) 6
Portuguese (6) 6
Hebrew (5) 5
Norwegian (4) 4
Hungarian (3) 3
Finnish (2) 2
Serbian (2) 2
Swedish (2) 2
Chinese (1) 1
Croatian (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 04/2016, Volume 12, Issue 4, pp. 423 - 431
Journal Article
Muscle & Nerve, ISSN 0148-639X, 04/2018, Volume 57, Issue 4, pp. 522 - 530
ABSTRACT Periodic paralyses (PPs) are rare neuromuscular disorders caused by mutations in skeletal muscle sodium, calcium, and potassium channel genes. PPs... 
treatment | periodic paralyses | review | acetazolamide | Andersen‐Tawil syndrome | channelopathies | dichlorphenamide | Andersen-Tawil syndrome | ACETAZOLAMIDE TREATMENT | EXERCISE TEST | FLECAINIDE | ANDERSEN-TAWIL-SYNDROME | SKELETAL-MUSCLE CHANNELOPATHIES | CHANNEL GENE SCN4A | WEAKNESS | KCNJ2 MUTATIONS | NEUROSCIENCES | CLINICAL NEUROLOGY | VENTRICULAR-ARRHYTHMIAS | CARBONIC-ANHYDRASE INHIBITORS | Behavior Therapy | Humans | Andersen Syndrome - diagnosis | Paralysis, Hyperkalemic Periodic - therapy | Hypokalemic Periodic Paralysis - diagnosis | Anti-Arrhythmia Agents - therapeutic use | Paralyses, Familial Periodic - therapy | Andersen Syndrome - therapy | Paralyses, Familial Periodic - diagnosis | Paralysis, Hyperkalemic Periodic - diagnosis | Potassium - therapeutic use | Diuretics - therapeutic use | Hypokalemic Periodic Paralysis - therapy | Acetazolamide - therapeutic use | Hydrochlorothiazide - therapeutic use | Carbonic Anhydrase Inhibitors - therapeutic use | Diuretics, Potassium Sparing - therapeutic use | Care and treatment | Gene mutations | Therapeutics | Muscles | Diuretics | Paralysis | Diagnosis | Genetic screening | Homeopathy | Materia medica and therapeutics | Calcium | Heredity | Skeletal muscle | Sodium | Carbonic anhydrase | Mutation | Potassium | Neuromuscular system | Invited Reviews | Invited Review
Journal Article
Wilderness & Environmental Medicine, ISSN 1080-6032, 2010, Volume 21, Issue 2, pp. 146 - 155
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2018, Volume 2018, Issue 7, pp. CD005647 - CD005647
Background Cryptococcal meningitis is a severe fungal infection that occurs primarily in the setting of advanced immunodeficiency and remains a major cause of... 
HIV Infections [complications] | Health Resources [supply & distribution] | Flucytosine [supply & distribution; therapeutic use] | Humans | ANTIRETROVIRAL THERAPY | Fluconazole [supply & distribution; therapeutic use] | MAINTENANCE THERAPY | MEDICINE, GENERAL & INTERNAL | Adult | Intracranial Hypertension [drug therapy] | Antifungal Agents [supply & distribution; therapeutic use] | Antihypertensive Agents [adverse effects] | Acute Disease | RANDOMIZED-TRIAL | FUNGAL BURDEN | PLUS FLUCYTOSINE | Meningitis, Cryptococcal [drug therapy] | Amphotericin B [supply & distribution; therapeutic use] | HIGH-DOSE FLUCONAZOLE | Acetazolamide [adverse effects] | DOUBLE-BLIND | Developing Countries | INFECTED PATIENTS | PLACEBO-CONTROLLED TRIAL | AMPHOTERICIN-B DEOXYCHOLATE | Amphotericin B - supply & distribution | Drug Administration Schedule | Meningitis, Cryptococcal - drug therapy | Fluconazole - supply & distribution | Induction Chemotherapy - methods | Health Resources - supply & distribution | Fluconazole - therapeutic use | Antifungal Agents - supply & distribution | Antifungal Agents - therapeutic use | Meningitis, Cryptococcal - mortality | Intracranial Hypertension - drug therapy | Acetazolamide - adverse effects | Flucytosine - therapeutic use | HIV Infections - complications | Network Meta-Analysis | Amphotericin B - therapeutic use | Drug Therapy, Combination | Flucytosine - supply & distribution | Index Medicus
Journal Article
Journal Article